About 200 reports

  • Middle East & African Biosimilar Market, Immunomodulators,
  • 5.2 OVERVIEW OF THE US BIOSIMILARS MARKET

The global biosimilar market was estimated to be valued at USD 3,474.01 million in 2017, and is expected to register a CAGR of 43.85% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 30% of the global market, in 2017, while Asia-Pacific region is anticipated to register the highest CAGR...

  • Biosimilar
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • US Approved Biosimilars
  • 2.3 Overview of Biosimilars

Scope of the Report The report entitled “Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)”, provides an analysis of global biosimilar market in terms of value. The report also provides a brief analysis of the global biologics market by value and market share by products. Furthermore, the report also assesses...

  • Biosimilar
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • BIOSIMILARS
  • Biosimilar Process

Global Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through Risk Management and Quality by Design Summary Government support for biosimilars is increasing in key geographical markets, given the cost saving opportunities that these products represent for national healthcare budgets. A...

  • Biosimilar
  • Therapy
  • World
  • Supply
  • Remicade group
  • BIOCON - MAJOR BIOSIMILARS IN PIPELINE
  • BIOSIMILARS MARKET - BY APPLICATIONS

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Biosimilar
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Biosimilars: Overview
  • Emergence of biosimilars

About Biosimilars Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovator’s product....

  • Biosimilar
  • Biocon Limited
  • Hospira, Inc.
  • Sandoz Inc.
  • Teva Pharmaceuticals Ltd.

ZYDUS CADILA Chapter ## Appendix: Abbreviations List of Tables Summary Table : Global Market for Biosimilars, by Type, Through 2022 Table ## : List of Biosimilars Produced in E.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical
  • World

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Biosimilar
  • Therapy
  • World
  • Market Shares
  • Market Size
  • Biosimilar opportunities
  • Emergence of biosimilars

About Oncology Biosimilars Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting....

  • Biosimilar
  • Biocon Limited
  • Celltrion, Inc.
  • Hospira, Inc.
  • Sandoz Inc.

Biosimilars Real World Evidence: Proving the point ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World

Global Biosimilars and Follow-On Biologics Market 2017-2027 ##.

  • Biopharmaceutical
  • Biosimilar
  • World
  • Market Shares
  • Market Size

Biosimilars Market Snapshot Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025 Table ## Global Oncology Biosimilars Market Size (US$ Mn) Forecast, by Disease Indication, 2015–2025 Table ## Global Oncology Biosimilars Marke

  • Biosimilar
  • Oncology
  • APAC
  • World
  • Market Size

Commercialisaton of Biosimilars: Multifunctional teamwork for success ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World

List Of Tables Table ## Global Insulin Biosimilars Market Outlook, By Region (2014-2023) ($MN) Table ## Global Insulin Biosimilars Market Outlook, By Biosimilars Type (2014-2023) ($MN) Table ## Global Insulin Biosimilars Market Outlook, By Rapid-Acting

  • Biosimilar
  • APAC
  • Europe
  • World
  • Forecast

Physician reluctance to use biosimilars interchangeably with the original product may prove to be an issue, albeit one that can be overcome with education efforts.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Forecast

Global Biosimilar Market Outlook 2022 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • World
  • Market Size

You can request one free hour of our analyst’s time when you purchase this market report.

  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • World
  • Market Size

Biosimilars: EU Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Pharmaceutical
  • Europe

APAC Biosimilar Market, Forecast 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Therapy
  • Market Size

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022 ##.

  • Biosimilar
  • Insulin
  • Pathology
  • World
  • Market Size

Biosimilars: US Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Therapy
  • United States

This report analyzes the global markets for " Biosimilar Drugs".

  • Biosimilar
  • APAC
  • North America
  • World
  • Market Size

Biosimilars Education: Addressing a significant unmet need ##.

  • Biopharmaceutical
  • Biosimilar
  • European Union
  • United States
  • World

Biosimilars Market, Europe, Forecast to 2025 ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • Forecast

PHARMA LEADER SERIES: ## TOP BIOSIMILAR DRUG MANUFACTURERS 2017-2027 ##.

  • Biopharmaceutical
  • Biosimilar
  • China
  • Company
  • Market Size

The Future of Biosimilars in the USA: Mapping critical uncertainties and the impact of future events ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • United States
  • Market Size

It’s no secret that launching biosimilars into emerging markets is a growth opportunity, but this is one area where it really does pay to look before you leap.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • India

Biosimilars: European Payer Perspectives ##.

  • Biopharmaceutical
  • Biosimilar
  • Generic Drug
  • Europe
  • European Union

The Future of Biosimilars in Europe: Mapping critical uncertainties and the impact of future events ##.

  • Biopharmaceutical
  • Biosimilar
  • Therapy
  • Europe
  • European Union

## Global Biosimilar Market Outlook, By Region (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Product (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Peptides (2013-2022) ($MN) ## Global Biosimilar Market Outlook, By Erythropoietin (2013-

  • Biosimilar
  • APAC
  • World
  • Forecast
  • Market Size